Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis
about
Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-AnalysisIsoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infectionEffectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort studyRapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisPrevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysisRifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysisResearch questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analysesThe impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the state of Andhra Pradesh, IndiaThe value of serum prealbumin in the diagnosis and therapeutic response of tuberculosis: a retrospective studyHas introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?Prevalence and risk factors for adult pulmonary tuberculosis in a metropolitan city of South IndiaThe Role of Adherence and Retreatment in De Novo Emergence of MDR-TBPrevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, PeruWhole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational StudyIn silico evaluation and exploration of antibiotic tuberculosis treatment regimensA Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant TuberculosisMDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosisWhat are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.Directly-observed intermittent therapy versus unsupervised daily regimen during the intensive phase of antituberculosis therapy in HIV infected patientsIsoniazid-resistant tuberculosis: a cause for concern?A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis.Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009Identifying multidrug resistance in previously treated tuberculosis patients: a mixed-methods study in Cambodia.Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing.Prevalence of tuberculosis and treatment outcome among university students in Northwest Ethiopia: a retrospective study.Tuberculosis chemotherapy in the 21 century: Back to the basics.Treatment of drug-resistant tuberculosis.A prospective study of tuberculosis drug susceptibility in sabah, malaysia, and an algorithm for management of isoniazid resistance.Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa.Target product profile of a molecular drug-susceptibility test for use in microscopy centers.Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.Rationing tests for drug-resistant tuberculosis - who are we prepared to miss?Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysisBurden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis
P2860
Q26781111-99B83805-99CE-4B69-81C0-88774451C74CQ28468519-838EB2B6-258E-4AFE-A960-F237890F938AQ28476713-E7EC2638-DBAE-4741-AEDE-2B1CBB461F6AQ28477435-53119A6C-6F98-45D4-B196-DF6DC715C9CFQ28477855-E274D57F-B448-48AE-954C-87E0B8C99774Q28478421-F2F82307-CDC5-45D5-9B8D-1352467D58C0Q28480467-6479E212-B025-40A8-9B76-C183F8A06C08Q28481610-A440F3A2-4D2C-48C4-BE9C-F039C2CD7165Q28534364-AB2C58E6-8245-46C2-AC8D-86618D2B2D26Q28535268-69006792-8D5F-4F38-A62A-FC1925A9ACEFQ28546196-F0B20861-99D1-44EF-A5CA-E15A09958711Q28546667-147FDA28-7A4F-49AD-A9BB-688E83BB6F89Q28550707-472130BA-DAF3-488D-96F0-33A93AB08EB7Q28551162-A4CA7B99-D2EA-4DC3-A314-59C924C56DC0Q28554475-95EACEEA-81ED-487B-B080-4DB4E3949282Q28607283-98ACE99D-4819-4A6B-8103-7046466D714BQ29048653-F12E88DD-E814-4372-A339-DBB5407A240CQ29247878-FE69CAFF-D01B-4C54-8248-DBB14319E49AQ30249635-1126983A-52E4-41CE-8DCF-03F7476D96F9Q33595994-359843ED-5B19-4EF0-B6A0-F176130538CDQ33809970-4A2145CB-6009-45B5-84D8-DD0481DADEBAQ33820505-3DE8F6CA-9391-4A34-91DE-6429211C81B8Q33847279-8CE4F400-3419-4185-9D6F-45176388166DQ33988089-990F38C4-F990-4508-A457-B54ACCBE8058Q34426078-8925ABEE-E815-4178-9DB4-E1252EDA4514Q34455442-420D5896-D163-4E0E-9827-605CA3984FC0Q34505509-857AE95C-171B-4C50-8932-01BC46ABE08CQ34708249-D5D53F0E-B3A5-4A9D-9E8F-8B03A655D067Q35025555-6A9894A0-9461-4F53-B0AC-5B30D8636288Q35183890-356A1391-9C67-4D75-9891-1A19E360646FQ35187176-F962F32C-B6E6-45C7-836E-4E4D03B1FA10Q35206899-924AD733-218F-432A-B309-ED9CAC0DA7A6Q35452446-E79BBE96-7D96-4D1C-B1B6-1D64D4D74FD9Q35588123-6DFE9D3D-0877-4F68-AD5D-9AC093E425D9Q35673445-6E4DD3A1-A85B-4C03-A288-40E0AC48F556Q35914813-D8E27376-10C9-4F6C-A340-C9FEA0DC5941Q35966925-73F6CD64-2DFF-439A-9D1A-FD254556C2EBQ36001543-96B8911D-5F9A-490A-BBE5-4842159675F8Q36386227-2E2D7C7C-D023-4802-B70C-6DA2DD258397Q36439006-D62DA638-CAF7-4CB0-8F93-95379FCACC80
P2860
Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Standardized treatment of acti ...... matic review and meta-analysis
@ast
Standardized treatment of acti ...... matic review and meta-analysis
@en
Standardized treatment of acti ...... matic review and meta-analysis
@nl
type
label
Standardized treatment of acti ...... matic review and meta-analysis
@ast
Standardized treatment of acti ...... matic review and meta-analysis
@en
Standardized treatment of acti ...... matic review and meta-analysis
@nl
prefLabel
Standardized treatment of acti ...... matic review and meta-analysis
@ast
Standardized treatment of acti ...... matic review and meta-analysis
@en
Standardized treatment of acti ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P921
P3181
P1433
P1476
Standardized treatment of acti ...... matic review and meta-analysis
@en
P2093
Andrea Benedetti
Andrew Vernon
Anita Paydar
Christian Lienhardt
Pai Madhukar
Sarah Royce
William Burman
P275
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1000150
P407
P50
P5008
P577
2009-09-01T00:00:00Z